TRAF6 Role Extends Beyond MDS to Affect Innate Immune Signaling A newly revealed mechanism that controls blood stem cell function may open doors to better treatments for a group of cancer-causing bone marrow disorders known as myelodysplastic syndromes (mds).
Read Featured Research| Research and Training Details | |
|---|---|
| Faculty | 23 |
| Joint Appointment Faculty | 14 |
| Research Fellows and Post Docs | 25 |
| Research Graduate Students | 21 |
| Total Annual Grant Award Dollars | $15,508,116 |
| Total Annual Industry Award Dollars | $76,488 |